Ignite Creation Date:
2025-12-24 @ 11:00 PM
Ignite Modification Date:
2025-12-30 @ 3:30 PM
Study NCT ID:
NCT00049569
Status:
COMPLETED
Last Update Posted:
2013-10-08
First Post:
2002-11-12
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Combination Chemotherapy and Imatinib Mesylate in Treating Children With Relapsed Acute Lymphoblastic Leukemia
Sponsor:
National Cancer Institute (NCI)
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | L1 Childhood Acute Lymphoblastic Leukemia | View |
| None | L2 Childhood Acute Lymphoblastic Leukemia | View |
| None | Non-T, Non-B Childhood Acute Lymphoblastic Leukemia | View |
| None | Recurrent Childhood Acute Lymphoblastic Leukemia | View |
| None | T-cell Childhood Acute Lymphoblastic Leukemia | View |
Keywords: